NSYSU’s Dr. Ming-Lung Yu, Dean of the College of Medicine and Senior Vice President, and Tsung-Hsien Lin, Distinguished Professor of the Department of Photonics, received the 2022 NSTC Academic Outstanding Research Awards
2023-06-27
The National Science and Technology Council (NSTC) announced the recipients’ list of the 2022 NSTC Academic Outstanding Research Award. Chair professor Dr. Ming-Lung Yu, Dean of the College of Medicine and Senior Vice President of National Sun Yat-sen University (NSYSU), and Tsung-Hsien Lin, Distinguished Professor of the Department of Photonics at NSYSU, received recognition from the award judges for the second time. Both Dr. Yu and Professor Lin have made significant contributions to different fields of scientific research in Taiwan. Dr. Yu is the 2021 top 2% Scientist in the world. His expertise includes gastroenterology, internal medicine, ultrasound medicine, molecular biology, epidemiology, Hepatitis B and C, fatty liver disease, liver cirrhosis, liver cancer, and translational medicine. He has dedicated much effort to the study of innovative micro-elimination of Hepatitis C, aiming to eliminate the disease in Taiwan thoroughly. Besides, Dr. Yu conducted a nationwide clinical cohort study to resolve the unmet needs of Hepatitis C in the post direct-acting antiviral (DAA) era, such as development of liver cancer after HCV eradication. Distinguished Professor Lin’s expertise includes liquid crystal optics, optical components, and foresight display technology. He also contributed much time and effort to strengthen international industry-academia cooperation by establishing a start-up company that develops innovative smart window technology.
Hepatitis C has been the major etiology of liver cirrhosis and liver cancer with a 2-3% prevalence in Taiwan. The prevalence is much higher than in nearby countries. Thus, the importance and urgency of Hepatitis C prevention and treatment cannot be ignored by the researchers in Taiwan. Dr. Yu spent years in the study of Hepatitis C mechanisms and prevention. His team has conducted the ERASE-C Hemodialysis HCV micro-elimination project to investigate the effectiveness and feasibility of referral treatment and on-site treatment aiming to implement HCV micro-elimination. They found that utilizing on-site treatment with pangenotypic regimen, sofosbuvir and velpatasvir, can raise the cure rate up to 93.6% by increasing treatment accessibility. The safety of this methodology was also proved. It has made the milestone of No-C hemodialysis more and more accessible.
Moreover, Dr. Yu’s team established the national Taiwan hepatitis C registry program (TACR) and outreach on-site treatment team to successfully develop the HCV micro-elimination utilizing pharmacoeconomics and outreach screening programs. The mission is to accomplish HCV elimination in Taiwan by 2025. Their effort and results have been recognized internationally in the associated academic fields. Dr. Yu was invited to be the key member conducting hepatitis C guidelines for the Asia-Pacific region in 2012, 2016, and 2019. He was the leading member conducting the 2020 Taiwan Hepatitis C Policy Guideline, requested by the Taiwan Association for the Study of the Liver (TASL). He also revolutionized the clinical management algorithm for HCV among patients with chronic kidney disease, which was included in the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline.
Tsung-Hsien Lin, the Distinguished Professor of the Department of Photonics at NSYSU, has made groundbreaking contributions in the photonic liquid crystal field. He developed the photonic crystals with the largest range of adjustable band gaps, the biggest single-crystal structure, and stable non-cubic crystals. His research results were published in many recognized international journals, such as Nature Materials, Nature Communications, Advanced Materials, and Optica. His study made photonic band customization possible and established an innovative perspective in the field of photonic crystal applications.
In addition to research, Professor Lin and students established an innovative start-up team to design and manufacture smart-window films. The window films designed by Professor Lin’s team are different from the traditional ones, which can be cut into any size and laminated on windows. The films are capable of image display, privacy protection, and high transmittance by switching different liquid crystal operation modes. Professor Lin’s team has been continuously receiving awards, including the 15th National Industrial Innovation Award, the Business Startup Award from the Ministry of Economic Affairs, the Entrepreneurship Excellence Award from MOST, and the Lite-in Gold Award of Influential Technical Award from LITE-ON Technology Corporation. The team was selected to participate in the Taiwan Tech Arena at the CES exhibition in 2018, 2019, and 2022, and was awarded CES Innovation Award in 2019. Except for applying academic technologies to industries, Professor Lin successfully made the international corporations that are listed in the global Top 100 companies invest more than NTD 10 million in developing related techniques. Professor Lin will keep building the cooperation platform to coordinate the resources and talents from laboratories, start-ups, and schools, aiming for a triple-win academia-industry environment.
The National Science and Technology Council (NSTC) announced the recipients’ list of the 2022 NSTC Academic Outstanding Research Award. Chair professor Dr. Ming-Lung Yu, Dean of the College of Medicine and Senior Vice President of National Sun Yat-sen University (NSYSU), and Tsung-Hsien Lin, Distinguished Professor of the Department of Photonics at NSYSU, received recognition from the award judges for the second time. Both Dr. Yu and Professor Lin have made significant contributions to different fields of scientific research in Taiwan. Dr. Yu is the 2021 top 2% Scientist in the world. His expertise includes gastroenterology, internal medicine, ultrasound medicine, molecular biology, epidemiology, Hepatitis B and C, fatty liver disease, liver cirrhosis, liver cancer, and translational medicine. He has dedicated much effort to the study of innovative micro-elimination of Hepatitis C, aiming to eliminate the disease in Taiwan thoroughly. Besides, Dr. Yu conducted a nationwide clinical cohort study to resolve the unmet needs of Hepatitis C in the post direct-acting antiviral (DAA) era, such as development of liver cancer after HCV eradication. Distinguished Professor Lin’s expertise includes liquid crystal optics, optical components, and foresight display technology. He also contributed much time and effort to strengthen international industry-academia cooperation by establishing a start-up company that develops innovative smart window technology.
Hepatitis C has been the major etiology of liver cirrhosis and liver cancer with a 2-3% prevalence in Taiwan. The prevalence is much higher than in nearby countries. Thus, the importance and urgency of Hepatitis C prevention and treatment cannot be ignored by the researchers in Taiwan. Dr. Yu spent years in the study of Hepatitis C mechanisms and prevention. His team has conducted the ERASE-C Hemodialysis HCV micro-elimination project to investigate the effectiveness and feasibility of referral treatment and on-site treatment aiming to implement HCV micro-elimination. They found that utilizing on-site treatment with pangenotypic regimen, sofosbuvir and velpatasvir, can raise the cure rate up to 93.6% by increasing treatment accessibility. The safety of this methodology was also proved. It has made the milestone of No-C hemodialysis more and more accessible.
Moreover, Dr. Yu’s team established the national Taiwan hepatitis C registry program (TACR) and outreach on-site treatment team to successfully develop the HCV micro-elimination utilizing pharmacoeconomics and outreach screening programs. The mission is to accomplish HCV elimination in Taiwan by 2025. Their effort and results have been recognized internationally in the associated academic fields. Dr. Yu was invited to be the key member conducting hepatitis C guidelines for the Asia-Pacific region in 2012, 2016, and 2019. He was the leading member conducting the 2020 Taiwan Hepatitis C Policy Guideline, requested by the Taiwan Association for the Study of the Liver (TASL). He also revolutionized the clinical management algorithm for HCV among patients with chronic kidney disease, which was included in the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline.
Tsung-Hsien Lin, the Distinguished Professor of the Department of Photonics at NSYSU, has made groundbreaking contributions in the photonic liquid crystal field. He developed the photonic crystals with the largest range of adjustable band gaps, the biggest single-crystal structure, and stable non-cubic crystals. His research results were published in many recognized international journals, such as Nature Materials, Nature Communications, Advanced Materials, and Optica. His study made photonic band customization possible and established an innovative perspective in the field of photonic crystal applications.
In addition to research, Professor Lin and students established an innovative start-up team to design and manufacture smart-window films. The window films designed by Professor Lin’s team are different from the traditional ones, which can be cut into any size and laminated on windows. The films are capable of image display, privacy protection, and high transmittance by switching different liquid crystal operation modes. Professor Lin’s team has been continuously receiving awards, including the 15th National Industrial Innovation Award, the Business Startup Award from the Ministry of Economic Affairs, the Entrepreneurship Excellence Award from MOST, and the Lite-in Gold Award of Influential Technical Award from LITE-ON Technology Corporation. The team was selected to participate in the Taiwan Tech Arena at the CES exhibition in 2018, 2019, and 2022, and was awarded CES Innovation Award in 2019. Except for applying academic technologies to industries, Professor Lin successfully made the international corporations that are listed in the global Top 100 companies invest more than NTD 10 million in developing related techniques. Professor Lin will keep building the cooperation platform to coordinate the resources and talents from laboratories, start-ups, and schools, aiming for a triple-win academia-industry environment.
Click Num:
Share